Physician profile
David Orsini
NPI 1043502263
$20,983.71
in general payments reported to CMS, 2019-2025
14 companies · $1,892 in 2025
The $1,892 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,121 · 2020: $1,585 · 2021: $5,437 · 2022: $4,028 · 2023: $4,306 · 2024: $1,615 · 2025: $1,892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,383 · Travel and Lodging: $1,285 · Long Term Medical Supply Or Device Loan: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,382.93 |
| Travel and Lodging | $1,284.62 |
| Long Term Medical Supply Or Device Loan | $145.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $15,498.49 | 2019-2025 | Variax, Hoffmann, Augment Injectable |
| Medinc of Texas | $1,963.00 | 2019-2020 | |
| Wright Medical Technology, INC. | $1,153.32 | 2019-2020 | |
| Depuy Synthes Sales INC. | $674.58 | 2024-2025 | Hammerlock, Na, Va-Lcp |
| Ossur Americas, INC. | $650.67 | 2024-2025 | |
| Paragon 28, INC. | $360.85 | 2019-2025 | Smart28, Bun-Yo-Matic, Apex 3d |
| Smith+Nephew, INC. | $210.31 | 2021-2025 | Bone Anchors With Arthroscopic Delivery System |
| Integra Lifesciences Corporation | $145.00 | 2023 | Acell |
| Medtronic, INC. | $142.29 | 2024 | Vanta Adaptivestim |
| Bioventus LLC | $109.44 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.89 | 2019 | |
| Abbott Laboratories | $21.33 | 2019 | |
| Core Surgical Group | $19.49 | 2025 | |
| Saluda Medical Americas, INC. | $6.05 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Orsini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.